There is no urgency for vaccinating children against meningitis as the prevalence is relatively low, say Canadian health authorities.
At the same experts have taken strong objection to a TV commercial promoting the vaccine Menactra manufactured by Sanofi Pasteur. The commercial shows what might happen if parents don't vaccinate their children but critics warn parents to examine the facts and not be swayed by such ads.
'The [TV] ads for the vaccine I've seen are very problematic,' Dr. Barbara Mintzes, a member of the Drug Assessment Working Group at the University of British Columbia, told CBC News. 'I find it really a problem because of the way it's playing into that parental concern to protect their child and using that to sell a product.'
Menactra protects against four strains of meningitis-causing bacteria.
On Oct. 18, the U.S. Food and Drug Administration allowed Sanofi Pasteur, to expand its use to children two to 10 years of age, in addition to the current age indication of 11 to 55 years.
But the Public Health Agency of Canada's National Advisory Committee (PHAC) on Immunization says that given the low incidence of the strains of meningitis covered by Menactra, it feels mass inoculations aren't necessary.
It decided in May not to recommend the vaccine for children aged two to 10 for coverage under provincial health plans, although Prince Edward Island and New Brunswick regions have decided to add Menactra to their childhood immunization schedules.